# Prevention of Tuberculosis in Prisons

> **NCT03028129** · PHASE4 · TERMINATED · sponsor: **Federal University of Mato Grosso** · enrollment: 467 (actual)

## Conditions studied

- Tuberculosis, Pulmonary
- Antibiotic Prophylaxis

## Interventions

- **DRUG:** Isoniazid 900 milligrams
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03028129
- **Lead sponsor:** Federal University of Mato Grosso
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-04
- **Primary completion:** 2019-08-10
- **Final completion:** 2019-08-10
- **Target enrollment:** 467 (ACTUAL)
- **Why stopped:** Interim analysis showed efficacy less than 2.5%.
- **Last updated:** 2019-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028129, "Prevention of Tuberculosis in Prisons". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03028129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*